Home
News
Latest News
People Moves
Business Briefs
Newsletters
Features
Features
Reprints
Surveys
Editorial Calendar
Web Exclusives
Issue Archive
Events
MM&M Awards 2012
txt4pharma
MM&M Virtual Summit
Webcasts
Leadership Exchanges
Whitepapers
Directories
Creative Portfolio
Mobile Guide
Interactive Guide
Pharmaceutical Marketers Directory
MM&M Service Directory
Agency Gallery
Direct Marketing Showcase
Medical Education Review
Sales Force Listings
Jobs
About Us
Subscriber Services
Contact Us
Media Information
Editorial Advisory Board
Drug Info
New Drug Dossier
Drug Database
Subscribe
Order Now
Subscriber Services
Newsletters
RSS
|
Login
|
Register
Continuing Medical Education (CME)
Has commercial support for CME bottomed out?
Marc Iskowitz
October 13, 2010
Industry support for continuing medical education (CME) has been waning the last two years, but some say the bottom may be in sight.
ACCME plan for limited transparency draws support
Marc Iskowitz
April 30, 2010
Comments to a recent ACCME proposal formed a clear consensus: Accredited med-ed providers who break the rules should not be identified, unless changes in their accreditation status occur.
"Facebook for pharmacists" to offer news, CE and community
Matthew Arnold
June 18, 2009
JMI Health is launching PharmQD, which aims to be something like a cross between LinkedIn and Facebook for pharmacy students, hospital and retail pharmacists, said JMI SVP, eproducts Tina Pang Mayer (pictured).
Coalition flags ACCME plans
Matthew Arnold
May 22, 2009
The Coalition for Healthcare Communication said it doesn't oppose ACCME's proposal to set up an independent entity for disbursal of CME funding - provided that it's not the only game in town and CME providers don't have to pay for it.
AMA ethics group rethinks CME funding
Matthew Arnold
May 14, 2009
A pair of American Medical Association committee reports urges that industry-funded CME be put on a tighter leash, but they're a far cry from the ban on commercial support called for by the AMA's Council on Ethical and Judicial Affairs a year ago.
WebMD to launch Medscape iPhone app
Ben Comer
May 07, 2009
WebMD hopes to extend its professional network reach with the launch of a Medscape iPhone application. The app will become available during the last week of May, or in early June, according to a WebMD spokesperson.
IOM: quit gifts, reps, samples
Matthew Arnold
April 28, 2009
Physicians and medical institutions should shun gifts, reps, samples and ghostwriting, said the Institute of Medicine's conflict of interest committee in its full recommendations.
ACCME weighs pharma-free labeling
Matthew Arnold
April 23, 2009
The Accreditation Council for Continuing Medical Education is considering offering an accreditation flagging CME as being free of drug and device industry support -- a kind of Good Housekeeping Seal for CME.
ACCME won't ban industry funding of CME
Matthew Arnold
April 10, 2009
The Accreditation Council for Continuing Medical Education said that for the time being, it won't ban commercial support of CME.
Associations should cut ties with pharma, says JAMA
Matthew Arnold
March 31, 2009
The Journal of the American Medical Association is calling for professional medical associations to sever all ties with the drug industry--with exception to journal advertising and exhibit hall fees, of course.
APA to phase out pharma-sponsored CME, dinners
Ben Comer
March 26, 2009
The American Psychiatric Association (APA) will put an end to industry-sponsored continuing medical education (CME) and meals served during its annual meetings, the association said Wednesday.
GSK to expand clinical trial disclosures
Matthew Arnold
March 26, 2009
GlaxoSmithKline said it will broaden its transparency policies to include greater disclosure of its clinical research and the physicians the company works with on clinical trials.
Iowa Senate passes harsh gifts, data ban bill
Matthew Arnold
March 20, 2009
Iowa's state Senate passed a healthcare bill containing some of the toughest restrictions on drug company contacts with physicians yet.
Massachusetts antes up with tough transparency law
Matthew Arnold
March 12, 2009
Massachusetts passed regulation governing drug and device company sales and marketing that the state's deputy counsel boasted is "the most stringent of the existing state laws" and "sets PhRMA and AdvaMed codes as the floor."
MedPAC calls for reporting of samples
Matthew Arnold
March 03, 2009
An influential advisory board urged Congress to impose far-reaching transparency rules on payments to healthcare professionals and organizations interacting with the drug industry--including reporting samples, in part to aid counterdetailing efforts.
Medtronic vows public disclosure of payments to docs
Matthew Arnold
February 24, 2009
Medtronic said it will disclose payments to US physicians starting in 2011.
BIO punts on PhRMA physician interaction code
Matthew Arnold
February 20, 2009
The Biotechnology Industry Organization (BIO) issued a statement calling on member companies to develop their own codes of conduct on interaction with physicians, but again stopped short of adopting the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals.
Pfizer hops on transparency bandwagon with disclosures
Matthew Arnold
February 09, 2009
Following the lead of peers like Lilly and GSK, Pfizer announced plans to publicly disclose payments to US physicians, healthcare professionals and clinical investigators in excess of $500 per year, along with non-monetary items worth more than $25.
Sunshine bill is back with sharper teeth
Matthew Arnold
January 22, 2009
Senators Chuck Grassley (R-IA) and Herb Kohl (D-WI) reintroduced their Physician Payments Sunshine Act, which would require that manufacturers and group purchasing organizations disclose payments to physicians of $100 or more.
Congressional pharma foes square off over committee gig
Matthew Arnold
November 07, 2008
Fight! Fight! Two leading congressional critics of the pharma industry—Rep. Henry Waxman (D-CA) and John Dingell (D-MI)—are at odds over a committee chairmanship.
Effort seeks to educate faculty on promotional vs. certified CME
Matthew Arnold
October 27, 2008
A new training effort aims to help medical education faculty distinguish between certified and promotional CME.
Lilly settlement with states demands even greater transparency
Matthew Arnold
October 09, 2008
Eli Lilly & Co.'s $62 million settlement with 32 states and the District of Columbia over off-label Zyprexa marketing comes with an agreement requiring, among other things, that the company furnish those state AGs with a list of all healthcare professionals paid more than $100 for promotional speaking and consulting in the US.
Minnesota med school weighing gift and grants ban
Matthew Arnold
October 06, 2008
The University of Minnesota Medical School is weighing a tough ban on gifts to physicians and requiring docs to publicly disclose all relationships with drug companies, according to a University newspaper.
Wanted: smarter reps, says survey
Matthew Arnold
September 29, 2008
A snap survey of physicians found a yearning for smarter sales reps who know their disease states back and forth and can use clinical studies in their details.
Lilly to post registry of physician payments
Matthew Arnold
September 24, 2008
Lilly announced plans to broaden its transparency efforts to include publicly disclosing payments to US physicians as well as grants.
Customized journal offers à la carte content
Matthew Arnold
September 23, 2008
Sequence Medical is launching what it claims to be the first-ever individually customizable medical journal in the US.
ACCME proposals imperil CME, critics say
Matthew Arnold
September 15, 2008
As ACCME's public comment period on a proposed restructuring of the CME funding structure drew to a close, industry groups blasted the accrediting body for what they see as an overreaction imperiling medical education.
ACCME data show commercial support for CME flat in 2007
Matthew Arnold
September 09, 2008
Total commercial support of accredited CME scarcely budged in 2007, rising 1% to $1.2 billion, while the share of commercial support going to publishing and education companies declined 4.2% to $594 million, according to the ACCME's annual report.
Stanford prohibits direct commercial CME sponsorship
Ben Comer
August 26, 2008
As of September 1, Stanford University School of Medicine will prohibit commercial sponsorship for specific CME courses or programs.
GSK to make grant info public
Matthew Arnold
August 21, 2008
GlaxoSmithKline will join Pfizer and Eli Lilly in reporting educational and charitable grants.
Video Exclusive
Web Exclusives
Five industry experts advise specialty pharma company on digital strategy
April 20, 2012
Specialty pharma company POZEN assembled a crack team of experts to help shape its digital strategy. Not only did POZEN share with us the text from their contributions, but you can watch exclusive video clips of their valuable perspectives right here.
MM&M Awards 2011 HIghlights
The Best MM&M Awards Ever!
MAHF Ceremony 2012
Photos from the Medical Advertising Hall of Fame Awards ceremony
Most Popular
Most Emailed
Most Recent
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Wolters Kluwer deals health analytics unit to private equity firm
Pharmas are from Mars, Payers are from Venus
Study: Young Latinas are key decision makers, prefer English
Coach vs. cancer in BMS-backed awareness effort
Indian conglomerate buys Manhattan Research parent for $635m
No-see docs are know-nothings when it comes to new drug info, study suggests
How CDC's hep.-C testing advice benefits drugmakers now
National plan seeks Alzheimer's treatment by 2025
Study: Young Latinas are key decision makers, prefer English
Wolters Kluwer deals health analytics unit to private equity firm
Pharmas are from Mars, Payers are from Venus
Indian conglomerate buys Manhattan Research parent for $635m
No-see docs are know-nothings when it comes to new drug info, study suggests
Goodbye Plavix, hello competition
Sales forces shrank in 2011, but not everywhere
Coach vs. cancer in BMS-backed awareness effort
National plan seeks Alzheimer's treatment by 2025
E-prescriptions boost adherence data
No-see docs are know-nothings when it comes to new drug info, study suggests
E-prescriptions boost adherence data
How CDC's hep.-C testing advice benefits drugmakers now
PhRMA's Washington wish list
Study: Young Latinas are key decision makers, prefer English
Pharmas are from Mars, Payers are from Venus
Goodbye Plavix, hello competition
Indian conglomerate buys Manhattan Research parent for $635m
Sales forces shrank in 2011, but not everywhere
National plan seeks Alzheimer's treatment by 2025
Popular Topics
Acquisition
Adherence
Agency
App
Celebrity
Clinical Trial
Co-Marketing
Conflict Of Interest
Diabetes
Diagnostics
Digital
Direct To Consumer (DTC)
Disease Awareness
Downsize
Education & Awareness
FDA
Government
Guidance
Health Plans
HMOs
Hospitals
Insurers
Law
Marketing Research
Sales Force